Value2022202320242025TTMSelling/general/admin expenses—4.28 B4.27 B4.22 B4.3 BResearch & development—1.21 B1.31 B1.26 B1.26 BOperating income—2.44 B2.63 B2.76 B2.65 BNon-Operating Income, Total—511 M454 M449 M412 MInterest expense, net of interest capitalized—616 M580 M540 M—Non-Operating Income, excl. Interest Expenses—-191 M-181 M-248 M318 MUnusual income/expense—86 M55 M157 M94 MPretax income—2.36 B2.58 B2.77 B2.58 BEquity in earnings—11 M8 M3 M-3 MTaxes—743 M531 M614 M604 MNon-controlling/minority interest—46 M57 M70 M68 MAfter tax other income/expense—————Net income before discontinued operations—1.57 B1.99 B2.08 B1.91 BDiscontinued operations—-4 M00—Net income—1.57 B1.99 B2.08 B1.91 BDilution adjustment—000—Preferred dividends—183 M00—Diluted net income available to common stockholders—1.39 B1.99 B2.08 B1.91 BBasic earnings per share (Basic EPS)—3.054.374.564.18Diluted earnings per share (Diluted EPS)—3.034.344.554.17Average basic shares outstanding—455 M456 M456 M—Diluted shares outstanding—458 M459 M458 M—EBITDA—14.06 B14.09 B15.18 B16.23 BEBIT—13.45 B13.51 B14.6 B15.41 BCost of revenue—————Other cost of goods sold—————Depreciation & amortization (cash flow)—610 M580 M578 M814 M
GE HealthCare Technologies Inc. - Common Stock
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
GE HealthCare's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
GE HealthCare was originally the healthcare division of the American conglomerate General Electric, which spun it off in 2023 as an independent, publicly traded company. It operates in more than 100 countries, with GE HealthCare major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India.